aTyr Pharma (ATYR) 2025 Conference June 05, 2025 02:00 PM ET Speaker0 Alright. Welcome, everyone, to twenty twenty five Jefferies Global Healthcare Conference. My name is Roger Song, one of the senior that covers SMICHA biotech at Jefferies, in The US. It's my pleasure to have the next fireside chat with entire pharma CEO Sanjay. Good afternoon, Sanjay. Speaker1 Hi, Roger. How are you? Speaker0 Very good. Alright. So, why not we just get right in, into your lead program, for the pulmonary sarcoidosis? I kno ...

Aligos Therapeutics (ALGS) 2025 Conference June 05, 2025 02:00 PM ET Speaker0 Okay. I'd like to thank the organizers of the conference for inviting us to speak today. My name is Lawrence Blatt. I'm the CEO and one of the founders of Oligos Therapeutics. I'm going talk about our pipeline and particularly our HPV drug. We're going to be making some forward looking statements today. Our pipeline is now moving into Phase II pipeline. So, we have ALG184, which is our capsid assembly modulator for the treatment o ...

nCino (NCNO) 2025 Conference June 05, 2025 01:40 PM ET Speaker0 Everybody, my name is Koji Ikeda. I am, one of the software analysts here at BofA. I am super thrilled to have Encino CFO Greg Ornstein here for a fireside chat. Thank you so much for being here. We really, really appreciate it. And so, yeah, I guess from a high level perspective, you know, for those in the room that are unfamiliar with nCino or those on the webcast that is unfamiliar with nCino, just to maybe spend a minute or two on what does ...

Lottery.com (LTRY) Conference June 05, 2025 01:30 PM ET Speaker0 Well, good afternoon, everyone. I'd like to introduce you to lottery.com. The stock symbol is l t r y. It currently has roughly a $40,000,000 market cap. I look at this year as a reset year, and the company may be viewed it as even an entirely new revamped company. And I welcome Lottery.commanagement and Matt to explain the outlook for Lottery.com. Thanks, Matt, for joining us, and, and thanks, Greg, as well. Speaker1 Thanks, Michael. Nice to ...

Raymond James Financial (RJF) 2025 Investor Day June 05, 2025 01:30 PM ET Speaker0 Right. We might be a minute or so But we'll just go ahead and get started. First of all, thank you all for coming. Good afternoon. I'm Christy Wah, Senior Vice President of Investor Relations, and welcome to Raymond James Financial's twenty twenty five Analyst and Investor Day. We're happy that so many of you were able to join in person here in our corporate headquarters in St. Petersburg, Florida. We do really value that you ...

CME Group (CME) Conference June 05, 2025 01:30 PM ET Speaker0 Welcome to the afternoon session of the twenty twenty five Global Exchange and Trading Conference. I'm Patrick Molley, senior research analyst covering the exchanges, brokers, and trading companies. It's a pleasure to welcome my next guest, CME Group Chairman and CEO, Terry Duffy. CME is the largest futures exchange in the world. We always love having Terry here. Terry, thanks for joining us. Speaker1 Pat, thank you very much, buddy. Speaker0 So, ...

Syndax Pharmaceuticals (SNDX) 2025 Conference June 05, 2025 01:25 PM ET Speaker0 Good afternoon, everyone. Thank you for attending Jefferies Global Healthcare Conference. My name is Baozhi, a senior biotech analyst biotech team here. And please join me and welcome CEO, Mr. Michael Metzger CMO, Mr. Nick Batwood and COO, Mr. Steve Closter from Syndax Pharmaceuticals for this fireside chat session. Welcome. Speaker1 Thank you, Kelly. Speaker0 Maybe let's start with a high level question. Last year 2024 was a v ...

Amylyx Pharmaceuticals (AMLX) 2025 Conference June 05, 2025 01:25 PM ET Speaker0 We're going to get started with our next session. I'm Andrew Tsai, senior biotech analyst at Jefferies. Thanks for tuning in. And it's my pleasure to have the Amalex team with me today. To my direct left, Justin Klee, co CEO I'm sorry, Josh Cohen, co CEO, and then to his left, Justin Klee, co CEO, as well. Welcome both of you. Speaker1 Thank you. Speaker2 Thanks, Emily. Speaker0 So for those in the audience who may be less fami ...

Emergent BioSolutions (EBS) 2025 Conference June 05, 2025 01:25 PM ET Speaker0 Okay. Speaker1 Good afternoon, and welcome to the Jefferies Global Healthcare Conference. My name is Victoria Gendron with the Jefferies Investment Banking Team, and it is with my great pleasure to introduce Richard Lindahl, the CFO of Emergent BioSolutions. Speaker0 Okay. Thank you very much, Victoria, and, thank you all for coming today. We appreciate your interest in our company. I'm going to start, with the standard safe harb ...

KALA BIO (KALA) 2025 Conference June 05, 2025 01:25 PM ET Speaker0 Go ahead and start. Welcome, everyone. First of all, I wanted to thank the Jefferies team for inviting us to provide an ups oh, I need to find the way. An update on Kala and remind everyone there will be likely some forward looking statements. So, Kala is a leader, in the emerging field of mesenchymal stem cell secretomes, and our focus is on rare ophthalmic diseases. We have an ongoing pivotal trial with our lead product, KPI o one two, for ...